Soleus Capital Management as of Sept. 30, 2020
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 63 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Essa Pharma Com New (EPIX) | 6.7 | $13M | 1.8M | 6.90 | |
| Iveric Bio | 5.0 | $9.5M | 1.7M | 5.64 | |
| OraSure Technologies (OSUR) | 4.0 | $7.6M | 625k | 12.17 | |
| Mersana Therapeutics (MRSN) | 3.9 | $7.3M | 393k | 18.62 | |
| Inhibrx | 3.9 | $7.3M | 407k | 18.00 | |
| Natera (NTRA) | 3.9 | $7.3M | 101k | 72.24 | |
| Quidel Corporation | 3.6 | $6.7M | 31k | 219.38 | |
| Vericel (VCEL) | 3.5 | $6.5M | 353k | 18.53 | |
| Immunomedics | 3.4 | $6.5M | 76k | 85.03 | |
| Sarepta Therapeutics (SRPT) | 3.4 | $6.5M | 46k | 140.43 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 3.4 | $6.5M | 510k | 12.67 | |
| Novocure Ord Shs (NVCR) | 3.1 | $5.8M | 52k | 111.31 | |
| Tcr2 Therapeutics Inc cs | 3.0 | $5.7M | 282k | 20.32 | |
| Xenon Pharmaceuticals (XENE) | 2.9 | $5.5M | 500k | 11.07 | |
| Compass Pathways Sponsored Ads (CMPS) | 2.9 | $5.5M | 157k | 34.90 | |
| Iradimed (IRMD) | 2.3 | $4.2M | 199k | 21.38 | |
| Zymeworks | 2.2 | $4.2M | 89k | 46.57 | |
| Horizon Therapeutics Pub L SHS | 2.2 | $4.1M | 52k | 77.68 | |
| Cardiff Oncology (CRDF) | 2.1 | $4.0M | 282k | 14.19 | |
| Eiger Biopharmaceuticals | 2.0 | $3.8M | 473k | 8.14 | |
| Adverum Biotechnologies | 2.0 | $3.8M | 364k | 10.30 | |
| Alexion Pharmaceuticals | 1.8 | $3.4M | 30k | 114.44 | |
| Biogen Idec (BIIB) | 1.7 | $3.3M | 12k | 283.66 | |
| Oak Street Health | 1.7 | $3.1M | 59k | 53.44 | |
| Dex (DXCM) | 1.7 | $3.1M | 7.6k | 412.24 | |
| SurModics (SRDX) | 1.6 | $3.0M | 77k | 38.91 | |
| Misonix | 1.6 | $2.9M | 250k | 11.73 | |
| Itamar Med Sponsored Ads | 1.5 | $2.9M | 141k | 20.43 | |
| Axonics Modulation Technolog (AXNX) | 1.5 | $2.8M | 54k | 51.05 | |
| Merck & Co (MRK) | 1.2 | $2.2M | 27k | 82.96 | |
| Zynex (ZYXI) | 1.1 | $2.1M | 118k | 17.45 | |
| Blueprint Medicines (BPMC) | 1.0 | $1.9M | 21k | 92.70 | |
| Provention Bio | 0.9 | $1.8M | 139k | 12.83 | |
| Protara Therapeutics Com Stk (TARA) | 0.9 | $1.7M | 100k | 16.83 | |
| Nevro (NVRO) | 0.9 | $1.7M | 12k | 139.28 | |
| Rafael Hldgs Com Cl B (RFL) | 0.9 | $1.6M | 105k | 15.50 | |
| Trillium Therapeutics Com New | 0.8 | $1.6M | 113k | 14.21 | |
| Axogen (AXGN) | 0.8 | $1.6M | 135k | 11.63 | |
| Lyra Therapeutics (LYRA) | 0.7 | $1.2M | 111k | 11.18 | |
| Larimar Therapeutics (LRMR) | 0.6 | $1.2M | 76k | 15.17 | |
| Revance Therapeutics (RVNC) | 0.6 | $1.0M | 42k | 25.13 | |
| Pieris Pharmaceuticals | 0.5 | $1.0M | 500k | 2.07 | |
| Medicenna Therapeutics Corp. (MDNAF) | 0.5 | $1.0M | 249k | 4.14 | |
| Gossamer Bio Note 5.000% 6/0 (Principal) | 0.5 | $1.0M | 1.0M | 1.02 | |
| Ionis Pharmaceuticals (IONS) | 0.5 | $932k | 20k | 47.43 | |
| Staar Surgical Com Par $0.01 (STAA) | 0.5 | $868k | 15k | 56.56 | |
| Insulet Corporation (PODD) | 0.5 | $859k | 3.6k | 236.51 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.5 | $853k | 10k | 83.63 | |
| Arena Pharmaceuticals Com New | 0.4 | $821k | 11k | 74.79 | |
| Kadmon Hldgs | 0.4 | $787k | 201k | 3.92 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.4 | $725k | 168k | 4.32 | |
| Harpoon Therapeutics | 0.4 | $722k | 43k | 17.00 | |
| Pacira Pharmaceuticals (PCRX) | 0.3 | $613k | 10k | 60.10 | |
| Enanta Pharmaceuticals (ENTA) | 0.3 | $526k | 12k | 45.74 | |
| Astrazeneca Sponsored Adr (AZN) | 0.3 | $504k | 9.2k | 54.76 | |
| Kymera Therapeutics (KYMR) | 0.3 | $495k | 15k | 32.34 | |
| Fate Therapeutics (FATE) | 0.2 | $388k | 9.7k | 39.95 | |
| Castle Biosciences (CSTL) | 0.2 | $323k | 6.3k | 51.52 | |
| Irhythm Technologies (IRTC) | 0.2 | $283k | 1.2k | 238.42 | |
| Affimed Therapeutics B V | 0.1 | $232k | 69k | 3.39 | |
| Constellation Pharmceticls I | 0.1 | $218k | 11k | 20.29 | |
| Insmed Note 1.750% 1/1 (Principal) | 0.1 | $195k | 180k | 1.08 | |
| Unum Therapeutics Ord | 0.1 | $112k | 48k | 2.34 |
